Laryngopharyngeal surgery option for outpatients
Laryngopharyngeal surgeries that are performed in an ambulatory setting demonstrate low complication and admission rates, suggesting that such procedures can be carried out safely on an outpatient...
View ArticleComplications of suppurative otitis media characterized
Researchers emphasize the importance of an early and accurate diagnosis of chronic suppurative otitis media followed by surgical therapy to prevent complications.
View ArticleGraft recommendation bursts onto eardrum repair scene
Researchers say that a 0.2-mm partial thickness graft is optimal for reconstruction of subtotal tympanic membrane perforation.
View ArticleMeasuring genetic diversity within tumor predicts outcomes of patients with...
A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.
View ArticleMass. Eye and Ear's OGSH launches new collaboration to care for people ENT...
Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat...
View ArticleIntraoperative RLN monitoring prior to thyroid surgery improves surgical...
Intraoperative recurrent laryngeal nerve (RLN) monitoring has gained popularity with approximately 53 percent of general surgeons and 65 percent of otolaryngologists using intraoperative nerve...
View ArticleStudy suggests potential therapeutic role of aspirin in inhibiting vestibular...
Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake...
View ArticleAspirin intake correlates with halted growth of lethal intracranial tumor
Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake...
View ArticleMATH biomarker with HPV status may provide improved outcomes in HNSCC patients
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer...
View ArticleAcclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for...
Acclarent, Inc. announced today the launch of the ACCLARENT AERA Eustachian Tube Balloon Dilation System for the treatment of adult patients with Eustachian Tube Dysfunction (ETD), a condition marked...
View ArticleScientists develop new system to treat a host of genetic conditions
As potential next-generation therapeutics and research tools, few life sciences technologies hold more promise than genome-editing proteins – molecules that can be programmed to alter specific genes in...
View ArticleSalicylates drugs reduce proliferation, viability of cultured vestibular...
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that...
View ArticleResearchers reveal new understanding of pathobiology behind vestibular...
Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and...
View ArticleStudy explores outcomes of thyroid surgery in professional singers
A diagnosis of thyroid cancer can be devastating to professional singers, because surgical removal of the thyroid commonly causes voice changes. Massachusetts Eye and Ear surgeons developed a neural...
View ArticleAspirin intake correlates with halted growth of lethal intracranial tumor
Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake...
View ArticleMATH biomarker with HPV status may provide improved outcomes in HNSCC patients
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer...
View ArticleAcclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for...
Acclarent, Inc. announced today the launch of the ACCLARENT AERA Eustachian Tube Balloon Dilation System for the treatment of adult patients with Eustachian Tube Dysfunction (ETD), a condition marked...
View ArticleScientists develop new system to treat a host of genetic conditions
As potential next-generation therapeutics and research tools, few life sciences technologies hold more promise than genome-editing proteins – molecules that can be programmed to alter specific genes in...
View ArticleSalicylates drugs reduce proliferation, viability of cultured vestibular...
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that...
View ArticleResearchers reveal new understanding of pathobiology behind vestibular...
Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and...
View Article
